Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. (Q36585761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Gene therapy progress and prospects: non-viral gene therapy by systemic delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Huang L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1313-1319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16953249%20AND%20SRC:MED&resulttype=core&format=json

Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Nuclear entry of nonviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Intracellular trafficking of nonviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Nanoparticle and targeted systems for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Systemic administration of naked DNA with targeting specificity to mammalian kidneys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Mechanistic studies of sequential injection of cationic liposome and plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Gene therapy progress and prospects: electroporation and other physical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Synchronous selection of homing peptides for multiple tissues by in vivo phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Intracellular routing of plasmid DNA during non-viral gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Aptamer:toxin conjugates that specifically target prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Aptamers against extracellular targets for in vivo applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

7 January 2021

Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

7 January 2021

Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

7 January 2021

Non-immunostimulatory nonviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

7 January 2021

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

7 January 2021

Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302838

7 January 2021